Mariner
AGL icon

Mariner’s Agilon Health AGL Stock Holding History

Mariner’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$179K Buy
23,716
+14,175
+149% +$229K ﹤0.01% 3196
2025
Q4 		$166K Buy
9,541
+7,760
+436% +$150K ﹤0.01% 3225
2025
Q3 		$45.9K Sell
1,781
-6,349
-78% -$240K ﹤0.01% 3456
2025
Q2 		$467K Buy
8,130
+2,802
+53% +$225K ﹤0.01% 2386
2025
Q1 		$577K Buy
5,328
+3,211
+152% +$279K ﹤0.01% 2093
2024
Q4 		$101K Sell
2,117
-630
-23% -$38.1K ﹤0.01% 3188
2024
Q3 		$270K Sell
2,747
-1,466
-35% -$189K ﹤0.01% 2666
2024
Q2 		$689K Sell
4,213
-120
-3% -$17.1K ﹤0.01% 1787
2024
Q1 		$661K Buy
4,333
+1,180
+37% +$196K ﹤0.01% 1822
2023
Q4 		$989K Sell
3,153
-739
-19% -$267K ﹤0.01% 1437
2023
Q3 		$1.73M Buy
3,892
+1,521
+64% +$687K ﹤0.01% 1036
2023
Q2 		$1.03M Buy
+2,371
New +$1.33M ﹤0.01% 1293

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Mariner's AGL Position: Q1 2026 in Review

Mariner increased its Agilon Health (AGL) stake by 149% in Q1 2026, buying an estimated $229K and bringing the position to 23,716 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #3196.

Mariner first reported a position in AGL in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.73M in Q3 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Mariner held 23,716 shares of Agilon Health worth $179K as of Q1 2026.
  • Mariner bought 14,175 Agilon Health shares in Q1 2026, an estimated $229K.
  • Agilon Health made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3196 holding.
  • Mariner first reported a position in Agilon Health in Q2 2023 and has held it in 12 quarters since.
  • Mariner's Agilon Health position peaked at $1.73M in Q3 2023.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.